ARUP Launches First Clinical Spectral Flow Cytometry Assay for MRD Assessment in Multiple Myeloma
Salt Lake City
Archived
•
July 20, 2026
•
3 views
SALT LAKE CITY, July 20, 2026 /PRNewswire/ -- ARUP Laboratories today announced the launch of ARUP CLARISPECT™ Multiple Myeloma MRD by Spectral Flow Cytometry. The new assay will characterize small neoplastic populations with greater confidence and sensitivity than conventional flow…
Source: https://www.tremontonleader.com/search/?f=rss&t=article&l=50&c=news* - Read Original
"We build AI or anything ICST"
"5000+ Emails weekly."
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!
Sponsored
"Because adventure is exploring the unknown"
